trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Low-dose and high-dose dexamethasone suppression tests are used to diagnose Cushing's syndrome

the verdict
SUPPORTED
the evidence backs this
Recorded sources
5 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Low-dose and high-dose dexamethasone suppression tests are widely utilized as standard clinical diagnostic and screening tools for Cushing's syndrome.

The analysis

Multiple retrieved papers consistently reference both low-dose and high-dose dexamethasone suppression tests as established methods for diagnosing and differentiating Cushing's syndrome.

Evidence for · 5
Recorded source metadata

Al‐Saadi, Diederich, Oelkers. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome. 1998. https://doi.org/10.1046/j.1365-2265.1998.00345.x

Refers to the high-dose dexamethasone suppression test as a mainstay in the differential diagnosis of Cushing's syndrome.

See more details
More for · 4
Recorded source metadata

Palai S, Sahoo BK, Mishra S, Mishra S, Pattanaik S, Jena D. Ectopic Cushing Syndrome Secondary to Corticotropin-secreting Wilms Tumor: A Rare Paraneoplastic Phenomenon.. 2026. https://doi.org/10.1210/jcemcr/luaf325

Notes the absence of cortisol suppression following low- and high-dose dexamethasone suppression tests in diagnosing ectopic Cushing syndrome.

Recorded source metadata

Chasan O, Besisik Terzioglu MB, Mutlu U, Dolen Burak D, Hacisahinogullari H, Gul N, Soyluk Selcukbiricik O, Kubat Uzum A, Yenidunya Yalin G. Prognostic nutritional index and inflammatory indices as predictors of perioperative infection in patients with Cushing syndrome: a retrospective single-center study.. 2026. https://doi.org/10.3389/fendo.2026.1798032

Evaluates the 1-mg dexamethasone suppression test (DST) as a predictor and diagnostic index in Cushing syndrome patients.

Recorded source metadata

Rivera-Martínez WA, Builes-Montaño CE, Román-González A, Builes-Barrera CA, Ramírez-Castaño MJ, Gutiérrez-Restrepo J. Differential diagnosis of ACTH-dependent Cushing's syndrome: Biochemical, imaging, and predictive approaches.. 2026. https://doi.org/10.1016/bs.vh.2026.03.002

Reviews initial laboratory tests including low-dose dexamethasone suppression and high-dose suppression for the differential diagnosis of Cushing's syndrome.

Recorded source metadata

Jack Klahr, Ty Brian Carroll, Robert Nerenz, Hershel Raff. SUN-067 The Reflex Dexamethasone Suppression Test: Development and Assessment of Reflexed Serum Dexamethasone Measurement for the Diagnosis of Cushing Syndrome. 2025. https://doi.org/10.1210/jendso/bvaf149.1652

Discusses the overnight 1 mg dexamethasone suppression test as a screening tool for Cushing syndrome.

The paper trail · every fact has a biography
first checked01 Aug 2026
judged → SUPPORTED · 8301 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.
trust me, bro: win the argument, pass the class, survive peer review.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt